Products
Dipyridamole was commercially available in many countries in the form of capsules in combination with acetylsalicylic acid (Asasantin). It had been approved in many countries since 1997. The drug is no longer marketed in many countries.
Structure and properties
Dipyridamole (C24H40N8O4, Mr = 504.6 g/mol)
Effects
Dipyridamole (ATC B01AC30) has antithrombotic properties.
Indications
- Secondary prevention of ischemic insults and transient ischemic attacks.
